Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

AllergX® Launches a Natural Alternative to Rx and OTC Allergy Treatments
  • USA - English


News provided by

Proheta Communications

Apr 05, 2018, 05:00 ET

Share this article

Share toX

Share this article

Share toX

AllergX® is a natural, 100% non-drowsy lozenge that lowers IgE levels before the release of histamine, the root cause of allergy symptoms.
AllergX® is a natural, 100% non-drowsy lozenge that lowers IgE levels before the release of histamine, the root cause of allergy symptoms.

NEW YORK (PRWEB) April 05, 2018 -- Spring may bring smiles, but for allergy sufferers, spring flowers threaten to deliver another season of runny noses, nasal congestion and general ach…choo misery. According to the American Academy of Allergy, 50 million Americans suffers from seasonal or year-round allergies. Until now, allergy sufferers have had to choose between the suffering and their over-the-counter allergy medications causing drowsiness, nervousness or other unwanted side effects.

AllergX® Allergy Defense Formula, the world’s only “pre-histamine”, regulates the release of histamine before the onset of the allergic response or allergy symptoms.

Post this

Enter the launch of AllergX® Allergy Defense Formula [pronounced al-ER-gex], an all-natural, non-drowsy alternative to OTC meds that has been clinically shown to restore a person’s normal immune response to allergens.

According to Board Certified allergists, allergies are not a normal state of health. An allergic reaction occurs in people with allergies - but not in non-allergic people - after they are exposed to harmless allergens, like pollens, grasses or pet dander. This reaction happens because allergic individuals over-produce the allergen antibody IgE which triggers the release of histamine. Histamine is linked to allergy symptoms such as sneezing, itchy eyes, runny nose and nasal congestion.

Board Certified Allergist and Immunologist Dr. Lyndon Mansfield, MD said: “IgE is one of the key antibodies that triggers the allergic response. Reducing IgE levels in your body, and keeping them low, reduces the chance of histamine and other allergy-provoking chemicals being released.”

“Allergies seem to worsen every year and OTC drugs aren’t always the best solution.” said Dr. Stanley Goldstein, MD, a Board-Certified specialist in adult and pediatric allergy, asthma and immunology, and pediatric pulmonology. “AllergX has been proven to work before the onset of allergy symptoms by targeting the root cause of allergies. In my opinion, a pre-histamine is a viable alternative.”

The primary ingredient in AllergX underwent extensive clinical studies on 2,500 allergy sufferers throughout the United States. Following a rigorous FDA-compliant study protocol, it was found that the AllergX formulation reduced IgE levels that are linked to allergy symptoms such as sneezing, nasal congestion and runny nose.

AllergX is the world’s only “pre-histamine”, which means it regulates the release of histamine before the onset of the allergic response or allergy symptoms.

AllergX is an all-natural formulation of three natural cobalamin analogues (in the vitamin B12 family) that are delivered in a carefully calculated ratio and dosage via cherry-flavored lozenges. FDA-approved clinical studies have shown that the main ingredient in this proprietary and patented formulation can restore the body’s normal response to seasonal and year-round allergens, which is no allergic response at all.

How AllergX® Works

AllergX works by naturally regulating the over-production of the allergen antibody IgE (Immunoglobulin E), which in individuals with seasonal or year-round allergies is produced in higher quantities than the body requires for a normal functioning immune system. Allergic individuals have an easily-corrected imbalance in their immune system that overproduces IgE. Higher levels of IgE can lead to a hypersensitive response to harmless substances (such as pollen or pet dander) by triggering the release of histamines. When histamines are released into the body, they cause what individuals call their “allergy symptoms”. AllergX effectively lowers and regulates the over-production of IgE before the release of histamine.

“Everyone lives with pollen, pet dander and other allergens,” added Dr. Goldstein. “Yet some persons have adverse reactions. AllergX helps restore a normal response to harmless allergens, which is no allergic response”.

AllergX is available online at http://www.allergx.com or by searching AllergX on Amazon. Users in the above clinical study reported positive results within 2-4 weeks of taking AllergX as directed. AllergX is an all-natural, non-drowsy formula that is both gluten-free and vegetarian. There are no contraindications or known drug interactions. Study participants reported no adverse effects.

About AllergX®

AllergX Allergy Defense Formula is a twice-daily, cherry-flavored, quick-dissolve lozenge that works prior to the release of histamines by lowering levels of Immunoglobulin (IgE, the key allergen antibody) which, in turn, can lessen allergy symptoms such as sneezing, nasal itch, runny nose and nasal congestion. AllergX has been clinically tested by U.S. Board Certified Allergists and has been shown to down-regulate the levels of IgE antibodies and to help restore a normal response to both seasonal and year-round allergens, which, according to renowned allergy researcher Dr. Paul H. Ratner, MD, is “no allergic response at all”. For best results, AllergX should be started prior to the beginning of allergy season, and continued daily throughout the season. AllergX is a proprietary, patented, all-natural, non-drowsy dietary supplement intended for use by adults and children 12 years of age and over. For company information visit http://www.exposurescientific.com.

Kevin Mercuri, Proheta Communications, +1 212-901-6914 Ext: 701, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.